Healthcare Sector

Members of Parliament invested in the Healthcare Sector

148 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£440.98	1,371.90%	£1,030,327.16
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£341.41	1,000.61%	£770,428.76
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£361.05	420.10%	£364,066.55
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£129.38	412.07%	£358,446.30
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£129.38	293.25%	£275,276.59
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£10,444.00	291.67%	£274,172.14
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£340.70	291.20%	£273,843.17
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£63.97	266.17%	£256,319.42
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£5.00	257.14%	£250,000.00
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£10,444.00	255.48%	£248,835.94
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£196.50	172.33%	£190,633.24
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£10,444.00	169.42%	£188,592.80
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£40.30	167.77%	£187,441.86
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£154.93	154.28%	£177,992.77
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£10,444.00	153.74%	£177,619.05
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£105.76	144.59%	£171,211.84
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£105.76	129.27%	£160,485.58
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£196.50	116.08%	£151,254.05
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£154.93	113.14%	£149,196.58
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£111.17	105.71%	£143,999.34
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.56	102.14%	£141,497.33
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£251.10	99.13%	£139,389.38
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£426.66	97.56%	£138,288.65
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£10,444.00	92.80%	£134,960.31
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£424.25	91.83%	£134,280.61
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£508.13	82.88%	£128,015.47
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£508.13	78.81%	£125,163.98
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£62.63	72.30%	£120,607.99
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£111.17	68.32%	£117,821.20
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£424.25	67.54%	£117,279.44
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,075.00	59.85%	£111,897.58
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£508.13	44.85%	£101,397.13
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£10,444.00	40.72%	£98,501.75
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£747.60	34.22%	£93,953.32
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£361.05	31.29%	£91,903.63
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£10,444.00	30.47%	£91,327.92
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£27.00	28.69%	£90,084.11
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£111.17	25.79%	£88,050.47
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£154.93	26.33%	£88,430.36
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£65.92	25.18%	£87,626.28
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.16	22.71%	£85,899.70
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£252.00	21.45%	£85,012.05
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£1.24	19.23%	£83,461.54
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£27.00	19.44%	£83,609.67
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£129.38	18.89%	£83,225.51
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£859.73	17.56%	£82,289.93
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£22.78	16.55%	£81,587.79
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£376.60	12.05%	£78,434.99
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£180.37	12.16%	£78,514.39
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£62.63	10.45%	£77,314.17
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£32.03	6.48%	£74,537.90
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£262.30	4.15%	£72,904.50
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£262.30	2.54%	£71,778.73
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£426.66	2.52%	£71,764.42
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£426.66	2.04%	£71,426.31
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£10,444.00	2.09%	£71,464.32
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£37.50	0.29%	£70,205.94
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£154.93	-4.20%	£67,060.97
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,922.00	-5.13%	£66,406.71
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£37.50	-5.04%	£66,472.52
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£37.50	-4.77%	£66,658.20
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£152.30	-6.46%	£65,477.21
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£154.93	-6.12%	£65,715.93
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£426.66	-7.09%	£65,033.97
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£252.00	-7.76%	£64,568.08
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£262.30	-8.19%	£64,266.71
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£152.30	-9.40%	£63,420.58
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£37.50	-11.37%	£62,042.07
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£10,444.00	-11.30%	£62,092.75
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£37.50	-12.34%	£61,360.45
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£10,444.00	-12.41%	£61,311.64
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£262.30	-13.43%	£60,597.36
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£424.25	-13.43%	£60,599.72
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£10,444.00	-13.14%	£60,801.73
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£1.66	-13.54%	£60,520.83
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£10,444.00	-14.08%	£60,141.49
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£262.30	-15.29%	£59,295.98
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£37.50	-14.81%	£59,631.99
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£37.50	-16.20%	£58,659.22
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£65.92	-17.02%	£58,086.60
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£20.50	-18.03%	£57,376.59
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£424.25	-18.13%	£57,308.95
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£185.00	-18.68%	£56,923.08
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£424.25	-21.12%	£55,217.26
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£196.50	-21.05%	£55,266.94
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£22.78	-21.51%	£54,943.07
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£426.66	-26.90%	£51,172.30
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£424.25	-28.63%	£49,962.14
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£37.50	-29.81%	£49,129.70
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£2.33	-29.61%	£49,274.92
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£184.27	-32.69%	£47,119.27
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£62.63	-38.41%	£43,112.40
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£1,604.00	-40.10%	£41,926.81
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£4.21	-40.95%	£41,332.40
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£28.25	-40.90%	£41,370.29
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£6.00	-46.67%	£37,333.33
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£28.25	-48.59%	£35,987.26
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£62.63	-48.98%	£35,715.68
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£62.63	-53.49%	£32,556.81
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.82	-54.03%	£32,178.10
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£1.53	-56.03%	£30,775.86
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£1.50	-62.03%	£26,582.28
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£122.10	-61.84%	£26,709.37
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£3.19	-69.96%	£21,026.37
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£31.00	-72.32%	£19,375.00
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.03	-74.85%	£17,607.75
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£27.39	-75.54%	£17,121.81
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£22.48	-76.40%	£16,519.00
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£2.60	-79.45%	£14,387.35
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£122.10	-80.07%	£13,952.01
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.27	-81.84%	£12,714.29
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£7.79	-83.11%	£11,826.07
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.80	-85.24%	£10,332.10
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£11.86	-88.28%	£8,203.56
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£1.88	-92.79%	£5,048.08
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£2.71	-93.74%	£4,382.07
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£1.36	-95.47%	£3,173.33
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.89	-95.80%	£2,938.68
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£0.57	-95.54%	£3,120.22
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.25	-97.92%	£1,458.92

Showing 1 to 148 of 148 entries

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.